SCHEDULE 13G/A: OrbiMed Entities Amend SI-BONE Stake, Disclosing 8.1% Aggregate Passive Ownership
Beneficial Ownership Amendment
OrbiMed Capital LLC and OrbiMed Advisors LLC have filed an amendment to their Schedule 13G, collectively reporting an 8.1% beneficial ownership stake in SI-BONE, Inc. as of March 31, 2025.
Summary
- OrbiMed Capital LLC and OrbiMed Advisors LLC, both Delaware-organized investment advisers, have filed an Amendment No. 4 to their Schedule 13G regarding their beneficial ownership of Common Stock in SI-BONE, Inc.
- As of March 31, 2025, OrbiMed Capital LLC beneficially owns 2,969,500 shares, representing 7.0% of SI-BONE, Inc.'s common stock, with sole voting and dispositive power over these shares.
- OrbiMed Advisors LLC beneficially owns 473,353 shares, representing 1.1% of SI-BONE, Inc.'s common stock, with shared voting and dispositive power over these shares.
- Collectively, the Reporting Persons (OrbiMed Capital LLC and OrbiMed Advisors LLC) hold an aggregate of 8.1% of SI-BONE, Inc.'s common stock.
- The shares are held in the ordinary course of business and not for the purpose of changing or influencing the control of SI-BONE, Inc.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently lead to a positive or negative sentiment regarding the company's operational performance or future prospects. It simply updates the public record on a significant passive stake.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of passive beneficial ownership by investment advisors in a publicly traded company, SI-BONE, Inc., which operates in the medical device sector, specifically focusing on sacroiliac joint dysfunction.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant passive ownership by institutional investors, which can influence market perception and liquidity.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires the filing of this statement (beneficial ownership calculation date). |
| 05/15/2025 | Date of execution and filing of the Joint Filing Agreement and Schedule 13G/A amendment. |
Keywords
SI-BONE Inc., OrbiMed Capital LLC, OrbiMed Advisors LLC, Schedule 13G/A, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.